AULAS E CONFERÊNCIAS

TCT 2008 - Transcatheter Cardiovascular Therapeutics

PLUS ESTUDO SYNTAX TCT 2008

The SYNTAX Trial: SYNergy between PCI with TAXUS and cardiac surgery. Trial Design and Philosophy
Friedrich W. Mohr, MD, PhD

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study. One Year Results of the PCI and CABG Registries
Friedrich W. Mohr, MD, PhD

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study. Primary Endpoint Results at One Yaer in the Randomized Cohort
Patrick Serruys - Friedrich Mohr

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study. Primary Endpoint Results at One Year in Subset of Patients With Left Main Disease
Patrick W. Serruys MD PhD - Friedrich W. Mohr MD

SYNTAX SCORE

Perspective: The Cup is Half Full. CABG "Best Scenario" Interpretation
Friedrich W. Mohr MD

TCT - 1° dia

SYNTAX Left main: The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study
Patrick W. Serruys MD PhD

A Prospective Randomized Trial of Paclitaxel-Eluting Stents vs. Coronary Artery Bypass Graft Surgery in Patients with Triple Vessel Coronary Artery Disease.
Friedrich W. Mohr

A Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents in Unprotected Left Main Coronary Artery Disease.
Julinda Mehilli

Fractional flow reserve versus angiography for guiding PCI in patients with multivessel coronary artery disease
Nico H.J. Pijls

Two-Year Follow-Up from a Prospective Randomized Trial Comparing a Zotarolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Martin Leon

A Prospective Randomized Study Using Optical Coherence Tomography to Evaluate Strut Coverage of Sirolimus-Eluting, Paclitaxel-Eluting, and Zotarolimus-Eluting Coronary Stents
Giulio Guaglium

Triple antiplatelet therapy significantly reduces ischemic events after drug-eluting stents implantation (DECREASE TRIAL)
Seong-Wook Park

The SOS (stenting of saphenous vein grafts) randomized controlled trial of a paclitaxel eluting stent vs a similar bare metal stent in saphenous vein graft lesions
Emmanouil Brilakis

A Prospective, Randomized Trial Examining the Safety and Efficacy of Systemic Hypothermia for the Prevention of Radiocontrast Nephropathy.
Gregg W. Stone

TCT - 2° dia

Stent Taxus superior ao stent convencional no tratamento do infarto agudo do miocárdio
Gregg W. Stone

A Prospective Randomized Trial of Bivalirudin vs. Unfractionated Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Acute ST-Segment Elevation Myocardial Infarction: Long-Term Follow-Up and Interaction with Stent Type
Roxana Mehran

Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent vs. Sirolimus-Eluting Stent vs. PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients.
Cheol-Hwan Lee, Seung-Jung Park

A prospective randomized trial of proximal microcirculatory protection in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
Karel T. Koch

A prospective randomized trial comparison of bivalirudin and unfractionated heparin plus protamine in patients undergoing elective percutaneous coronary intervention
David Antoniucci

A Prospective Randomized Trial Comparison of Bivalirudin and Unfractionated Heparin Plus Tirofiban in Patients with Diabetes Mellitus Undergoing Elective Percutaneous Coronary Intervention
Carlo Briguori

Prolonged Bivalirudin Infusion Versus Intraprocedural only RandomIzed study. The PROBI VIRI study
Bernardo Cortese

Eptifibatide não eficaz como adjuvante à reperfusão mecânica
Michel R. Le May

A prospective randomized Trial of tirofiban and abciximab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
Francesco Saia


TCT - 3º Dia

A Prospective Randomized Comparison of Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
Jens F. Lassen

A Prospective Randomized Comparison of a Single Drug-Eluting Stent Provisional Strategy vs. Routine Dual Drug-Eluting Stents for Coronary Bifurcation Lesions
David J. Hildick-Smith

A Prospective Randomized Trial Comparing Polymer-Free Rapamycin-Eluting and Probucol-Eluting Stents, Polymer-Based Sirolimus-Eluting Stents, and Zotarolimus-Eluting Stents in Patients with Coronary Artery Disease
Robert A. Byrne

A Large-Scale Registry Evaluating a Novel Self-Expanding Drug-Eluting Bifurcation Stent: Clinical, Angiographic, and IVUS Results
Stefan Verheye

A Large-Scale Registry Examining the Safety and Efficacy of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
Leif Thuesen

A Large-Scale Registry Examining the Rates of Stent Thrombosis After Implantation of Zotarolimus-Eluting and Everolimus-Eluting Stents in Patients with Coronary Artery Disease
Jose M. de la Torre Hernandez

A Multicenter Registry Evaluating Neuroprotection During Carotid Stenting with a Novel Flow Reversal System
L. Nelson Hopkins

A Multicenter Registry Evaluating Neuroprotection During Carotid Stenting with a Novel Distal Protection Device
Subbarao V. Myla

Novo dispositivo para troca valvular aórtica percutânea é testado
Joachim Schofer